最新消息 News & Events
提供給你最即時的診所資訊!
貼心提醒! 您可以先來電掛號
或利用本站網路掛號系統，以免久候
最新消息 The most professional medical team to take care of people's health
目前位置：首頁 > 最新消息
2015-03-12對於過敏性鼻炎的治療
美國的耳鼻喉科醫學會邀集全美的耳鼻喉科專家，在2014年5月開會討論並訂立最新的過敏性鼻炎的治療準則，同時將這治療準則於2015年刊登於美國著名的醫學期刊Otolaryngology—Head and Neck Surgery以為大家治療的依據。
其中有幾個重點：
1.第二代的抗組織胺及鼻腔局部類固醇噴劑，仍被視為過敏性鼻炎最有效的治療方式。
2.台灣民眾熟悉的”欣流”這類的藥物，因效果等於或不及於抗組織胺的效果，加上價格貴上許多，所以在一般情況下，不建議作為過敏性鼻炎患者的第一線用藥。
3.過敏原檢測：對於診斷困難或無法確立診斷或若是知道過敏原的種類可以增進治療效果的病患，以及對於治療一直沒有起色的過敏性鼻炎患者，可建議他們做過敏源檢測。
摘錄原文如下：
STATEMENT 7. ORAL ANTIHISTAMINES: Clinicians should recommend oral second-generation/less sedating antihistamines for patients with AR and primary complaints of sneezing and itching.
STATEMENT 6. TOPICAL STEROIDS: Clinicians should recommend intranasal steroids for patients with a clinical diagnosis of AR whose symptoms affect their quality of life.
STATEMENT 9. ORAL LEUKOTRIENE RECEPTOR ANTAGONISTS (LTRAs):Clinicians should not offer LTRAs as primary therapy for patients with AR.
STATEMENT 2. ALLERGY TESTING: Clinicians should perform and interpret, or refer to a clinician who can perform and interpret, specific IgE (skin or blood) allergy testing for patients with a clinical diagnosis of AR who do not respond to empiric treatment, or when the diagnosis is uncertain, or when knowledge of the specific causative allergen is needed to target therapy.
其中有幾個重點：
1.第二代的抗組織胺及鼻腔局部類固醇噴劑，仍被視為過敏性鼻炎最有效的治療方式。
2.台灣民眾熟悉的”欣流”這類的藥物，因效果等於或不及於抗組織胺的效果，加上價格貴上許多，所以在一般情況下，不建議作為過敏性鼻炎患者的第一線用藥。
3.過敏原檢測：對於診斷困難或無法確立診斷或若是知道過敏原的種類可以增進治療效果的病患，以及對於治療一直沒有起色的過敏性鼻炎患者，可建議他們做過敏源檢測。
摘錄原文如下：
STATEMENT 7. ORAL ANTIHISTAMINES: Clinicians should recommend oral second-generation/less sedating antihistamines for patients with AR and primary complaints of sneezing and itching.
STATEMENT 6. TOPICAL STEROIDS: Clinicians should recommend intranasal steroids for patients with a clinical diagnosis of AR whose symptoms affect their quality of life.
STATEMENT 9. ORAL LEUKOTRIENE RECEPTOR ANTAGONISTS (LTRAs):Clinicians should not offer LTRAs as primary therapy for patients with AR.
STATEMENT 2. ALLERGY TESTING: Clinicians should perform and interpret, or refer to a clinician who can perform and interpret, specific IgE (skin or blood) allergy testing for patients with a clinical diagnosis of AR who do not respond to empiric treatment, or when the diagnosis is uncertain, or when knowledge of the specific causative allergen is needed to target therapy.
 |  |
